NL279406A - - Google Patents

Info

Publication number
NL279406A
NL279406A NL279406DA NL279406A NL 279406 A NL279406 A NL 279406A NL 279406D A NL279406D A NL 279406DA NL 279406 A NL279406 A NL 279406A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL279406A publication Critical patent/NL279406A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL279406D 1961-06-16 NL279406A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH707361A CH396008A (de) 1961-06-16 1961-06-16 Verfahren zur Herstellung von Sulfonamiden der Pyrimidinreihe

Publications (1)

Publication Number Publication Date
NL279406A true NL279406A (cg-RX-API-DMAC10.html)

Family

ID=4319495

Family Applications (1)

Application Number Title Priority Date Filing Date
NL279406D NL279406A (cg-RX-API-DMAC10.html) 1961-06-16

Country Status (8)

Country Link
US (1) US3132139A (cg-RX-API-DMAC10.html)
BE (1) BE618639A (cg-RX-API-DMAC10.html)
CH (1) CH396008A (cg-RX-API-DMAC10.html)
DE (1) DE1218454B (cg-RX-API-DMAC10.html)
DK (1) DK98960C (cg-RX-API-DMAC10.html)
GB (1) GB951026A (cg-RX-API-DMAC10.html)
NL (1) NL279406A (cg-RX-API-DMAC10.html)
OA (1) OA00944A (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319592A1 (en) 1998-02-03 1999-08-05 University Of Maryland Method for the stimulation of sperm production and gonadal development in animals
GB0217431D0 (en) * 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
EP2311827A1 (en) * 2004-08-28 2011-04-20 AstraZeneca AB Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators.
CA2730477A1 (en) * 2008-07-16 2010-01-21 Astrazeneca Ab Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410793A (en) * 1940-03-01 1946-11-05 American Cyanamid Co Sulfonamido pyrimidines
GB866843A (en) * 1958-12-08 1961-05-03 Ici Ltd Sulphonamidopyrimidines
BE588170A (fr) * 1959-03-04 1960-09-01 Ici Ltd Composés hétérocycliques.

Also Published As

Publication number Publication date
GB951026A (en) 1964-03-04
BE618639A (fr) 1962-12-14
CH396008A (de) 1965-07-31
DE1218454B (de) 1966-06-08
DK98960C (da) 1964-06-08
OA00944A (fr) 1968-03-22
US3132139A (en) 1964-05-05

Similar Documents

Publication Publication Date Title
AT224007B (cg-RX-API-DMAC10.html)
BE600261A (cg-RX-API-DMAC10.html)
BE602153A (cg-RX-API-DMAC10.html)
BE458606A (cg-RX-API-DMAC10.html)
BE475425A (cg-RX-API-DMAC10.html)
BE624141A (cg-RX-API-DMAC10.html)
BE472265A (cg-RX-API-DMAC10.html)
BE164003A (cg-RX-API-DMAC10.html)
BE613948A (cg-RX-API-DMAC10.html)
BE600768A (cg-RX-API-DMAC10.html)
BE597570A (cg-RX-API-DMAC10.html)
BE621821A (cg-RX-API-DMAC10.html)
BE599210A (cg-RX-API-DMAC10.html)
BE601844A (cg-RX-API-DMAC10.html)
BE601042A (cg-RX-API-DMAC10.html)
BE602469A (cg-RX-API-DMAC10.html)
BE600124A (cg-RX-API-DMAC10.html)
BE601847A (cg-RX-API-DMAC10.html)
BE568568A (cg-RX-API-DMAC10.html)
BE567723A (cg-RX-API-DMAC10.html)
BE601041A (cg-RX-API-DMAC10.html)
BE601970A (cg-RX-API-DMAC10.html)
BE464928A (cg-RX-API-DMAC10.html)
BE599016A (cg-RX-API-DMAC10.html)
BE622907A (cg-RX-API-DMAC10.html)